Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathway

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Nord, Karolin H ^a   Nilsson, Jenny ^a   Arbajian, Elsa ^a   Von Steyern, Fredrik Vult ^a   Brosjö, Otte ^b   Cleton Jansen, Anne Marie ^c   Szuhai, Karoly ^c   Hogendoorn, Pancras C W ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BONE DEVELOPMENT; CARCINOGENESIS; CHILD; CHROMOSOME 22; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CHROMOSOME DELETION; CLINICAL ARTICLE; FEMALE; GENE; GENE DELETION; GENE FUNCTION; GENE REARRANGEMENT; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; KREMEN1 GENE; MALE; MIDDLE AGED; MN1 GENE; NF2 GENE; OSTEOBLASTOMA; OSTEOMA; OSTEOSARCOMA; PATHOGENESIS; PROTEIN EXPRESSION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; WNT SIGNALING PATHWAY; YOUNG ADULT; ZNRF3 GENE;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; CLUSTER ANALYSIS; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MUTATION; OSTEOBLASTOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; WNT SIGNALING PATHWAY; YOUNG ADULT;

EID: 84893164853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080725     Document Type: Article

References (30)

1. de Andrea CE, Bridge JA, Schiller A (2013) Osteoblastoma. In: CDM FletcherJA BridgePCW HogendoornF Mertens. WHO classification of tumours of soft tissue and bone. Lyon: International Agency for Research on Cancer. pp. 279-280.
2. Horvai A, Klein M (2013) Osteoid osteoma. In: CDM FletcherJA BridgePCW HogendoornF Mertens. WHO classification of tumours of soft tissue and bone. Lyon: International Agency for Research on Cancer. pp. 277-278.
3. Radig K, Schneider-Stock R, Mittler U, Neumann HW, Roessner A (1998) Genetic instability in osteoblastic tumors of the skeletal system. Pathol Res Pract 194: 669-677. doi:10.1016/S0344-0338(98)80125-8. PubMed: 9820862.
4. Rosenberg AE, Cleton-Jansen AM, de Pinieux G, Deyrup AT, Hauben E et al. (2013) Conventional osteosarcoma. In: CDM FletcherJA BridgePCW HogendoornF Mertens. WHO classification of tumours of soft tissue and bone. Lyon: International Agency for Research on Cancer. pp. 282-288.
5. Mitelman F, Johansson B, Mertens F, editors (2013) Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. Retrieved from http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed 2013 April 2.
6. Cleton-Jansen AM, Anninga JK, Briaire-de Bruijn IH, Romeo S, Oosting J et al. (2009) Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Br J Cancer 101: 1909-1918. doi:10.1038/sj.bjc.6605405. PubMed: 19888226.
7. Shaffer LG, Slovak ML, Campbell LJ (2009) An International System for Human Cytogenetic Nomenclature. Basel: S. Karger Publishing House.
8. Mertens F, Mandahl N, Örndahl C, Baldetorp B, Bauer HCF et al. (1993) Cytogenetic findings in 33 osteosarcomas. Int J Cancer 55: 44-50. doi:10.1002/ijc.2910550109. PubMed: 8344751.
9. Nord KH, Magnusson L, Isaksson M, Nilsson J, Lilljebjörn H et al. (2010) Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma. Proc Natl Acad Sci U S A 107: 21122-21127. doi:10.1073/pnas.1013512107. PubMed: 21078971.
10. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK et al. (2004) Detection of large-scale variation in the human genome. Nat Genet 36: 949-951. doi:10.1038/ng1416. PubMed: 15286789.
11. Cai Y, Mohseny AB, Karperien M, Hogendoorn PCW, Zhou G et al. (2010) Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma. J Pathol 220: 24-33. doi:10.1002/path.2628. PubMed: 19882675.
12. Baruffi MR, Volpon JB, Barbieri Neto J, Casartelli C (2001) Osteoid osteomas with chromosome alterations involving 22q. Cancer Genet Cytogenet 124: 127-131. doi:10.1016/S0165-4608(00)00327-7. PubMed: 11172903.
13. Hao HX, Xie Y, Zhang Y, Charlat O, Oster E et al. (2012) ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485: 195-200. doi:10.1038/nature11019. PubMed: 22575959.
14. Mao B, Wu W, Davidson G, Marhold J, Li M et al. (2002) Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Nature 417: 664-667. doi:10.1038/nature756. PubMed: 12050670.
15. MacDonald BT, Tamai K, He X (2009) Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26. doi:10.1016/j.devcel. 2009.06.016. PubMed: 19619488.
16. Koo BK, Spit M, Jordens I, Low TY, Stange DE et al. (2012) Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488: 665-669. doi:10.1038/nature11308. PubMed: 22895187.
17. Ellwanger K, Saito H, Clément-Lacroix P, Maltry N, Niedermeyer J et al. (2008) Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density. Mol Cell Biol 28: 4875-4882. doi:10.1128/MCB. 00222-08. PubMed: 18505822.
18. Morvan F, Boulukos K, Clément-Lacroix P, Roman Roman S, Suc-Royer I et al. (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21: 934-945. doi:10.1359/jbmr.060311. PubMed: 16753024.
19. Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C et al. (2012) Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52: 145-156. PubMed: 23032104.
20. Fujimori S, Novak H, Weissenböck M, Jussila M, Gonçalves A et al. (2010) Wnt/β-catenin signaling in the dental mesenchyme regulates incisor development by regulating Bmp4. Dev Biol 348: 97-106. doi:10.1016/j.ydbio.2010.09.009. PubMed: 20883686.
21. Lee YC, Cheng CJ, Bilen MA, Lu JF, Satcher RL et al. (2011) BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res 71: 5194-5203. doi:10.1158/1538-7445.AM2011-5194. PubMed: 21670081.
22. Nuñez F, Bravo S, Cruzat F, Montecino M, De Ferrari GV (2011) Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells. PLOS ONE 6: e18562. doi:10.1371/journal.pone. 0018562. PubMed: 21494638.
23. Lee HW, Kim SY, Kim AY, Lee EJ, Choi JY et al. (2009) Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells 27: 2254-2262. doi:10.1002/stem.144. PubMed: 19522015.
24. Lowy AM, Clements WM, Bishop J, Kong L, Bonney T et al. (2006) β-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res 66: 4734-4741. doi:10.1158/0008-5472.CAN-05-4268. PubMed: 16651426.
25. Tamamura Y, Otani T, Kanatani N, Koyama E, Kitagaki J et al. (2005) Developmental regulation of Wnt/β-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem 280: 19185-19195. doi:10.1074/jbc.M414275200. PubMed: 15760903.
26. Gómez García EB, Knoers NVAM (2009) Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder. Lancet Oncol 10: 727-735. doi:10.1016/S1470-2045(09)70167-6. PubMed: 19573802.
27. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (2013) WHO classification of tumours of soft tissue and bone. Lyon: International Agency for Research on Cancer.
28. Zhang X, Dowd DR, Moore MC, Kranenburg TA, Meester-Smoor MA et al. (2009) Meningioma 1 is required for appropriate osteoblast proliferation, motility, differentiation, and function. J Biol Chem 284: 18174-18183. doi:10.1074/jbc.M109.001354. PubMed: 19386590.
29. Zhou L, Hanemann CO (2012) Merlin, a multi-suppressor from cell membrane to the nucleus. FEBS Lett 586: 1403-1408. doi:10.1016/j.febslet.2012.03.016. PubMed: 22595235.
30. Davidson TB, Sanchez-Lara PA, Randolph LM, Krieger MD, Wu SQ et al. (2012) Microdeletion del(22)(q12.2) encompassing the facial development- associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature. BMC Med Genet 13: 19. doi:10.1186/1471-2350-13-19. PubMed: 22436304.